Dystonia; Orofacial Clinical Trial
— rétroBODOMOfficial title:
Outcome of Botulinum Toxin Treatment for Oromandibular Dystonia
Verified date | November 2017 |
Source | Fondation Ophtalmologique Adolphe de Rothschild |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Symptoms of oromandibular dystonia can be alleviated by injections of botulinum toxin. The scope of this study is to describe the efficacy of this procedure, by a retrospective systematic review of patients medical charts
Status | Completed |
Enrollment | 240 |
Est. completion date | July 12, 2016 |
Est. primary completion date | April 1, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patient suffering from oromandibular dystonia - Medical follow up in the Fondation Ophtalmologique Rothschild (Paris) - Treatment by at least one session of botulinum toxin injection Exclusion Criteria: - Patient cannot assess symptoms improvement using a Likert scale |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Fondation Ophtalmologique Adolphe de Rothschild |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical improvement score | Likert scale for the assessment of the clinical improvement after treatment | Two months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03428009 -
Dystonia Genotype-Phenotype Correlation
|